No human trial has tested ipamorelin for GH optimization, body composition, or anti-aging endpoints
Owing to their metabolic effects, GLP1RAs are also considered for the treatment of several other lifestyle-induced conditions, such as obesity, prediabetes and liver disease
In the SUSTAIN 1-7 series of clinical trials which investigated the effectiveness of once weekly semaglutide injections (Ozempic) for the treatment of diabetic and obese patients, semaglutide (Ozempic) consistently demonstrated significant reductions in HbA1c levels compared to placebo and other usual diabetes medications (metformin, sitagliptin, dulaglutide)
The starting Semaglutide dose is usually lower and gradually increased under medical supervision
Your pituitary normally releases GH in sharp bursts, especially during deep sleep